The groundbreaking approach of this peptide represents a major advance in the management of the condition. Unlike existing drugs, tirzepatide impacts dual pathways – glucagon-like peptide-1 (GLP-1) and the GIP https://tirzepatide-peptide548494.arwebo.com/64654254/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment